HB5011

N/A

Report date: 2025/12/23 17:47:51

Base Information

Drug NameHB5011
Drug Alias NameHB5011HB-5011
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHieraBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesHieraBio Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A